For millennia individuals have known that sleep is altered during sickness, and indeed many follow the advice to get sleep as an aid for recuperation from disease states. Hippocrates, more than 2400 years ago, made reference to the role sleep played in pathology. Yet systematic studies of sleep-immune interactions began just 30 years ago. During these past three decades, much progress has been made in our understanding of sleep-immune interactions during health and pathology.
Modern studies of sleep-immune interactions grew out of a subspecialty of endocrinology that focused on humoral regulation of sleep. Humoral theories of sleep posited that substances increased during waking, and when they reached some critical threshold, induced subsequent sleep. The first studies that directly tested these hypotheses were published in 1909 by Ishimori and in 1913 by Legendre and Pieron (Ishimori, 1909; Legendre and Piéron, 1910, 1913) . These pioneering studies used the same approach: cerebrospinal fluid from sleep deprived dogs was injected into rested recipient dogs. The recipient dogs fell into a deep, narcosis-like sleep state. Although these findings were replicated in various ways during the next 60 years, e.g. Schnedorf and Ivy (Schnedorf and Ivy, 1939) and Borbély et al. (Sachs et al., 1976) , it was to take almost 80 years before likely candidates mediating these ''hypnotoxin effects'' were identified.
During the 1960s and 1970s, several groups were using this approach in an attempt to identify substances involved in sleep regulation. This type of research was by this time being referred to as ''sleep factor research'' and delta sleep inducing peptide (Schoenenberger et al., 1977) was the first to be identified. In the 1980's several additional substances, isolated from brains derived from sleep deprived animals were characterized, including uridine (Honda et al., 1984) and a muramyl peptide (Krueger et al., 1982) . The latter finding provided a link between sleep and the immune system because it was known at the time that muramyl peptides were components of bacterial cell walls and induced the production of immune response modifiers.
A direct connection between immunocytes and sleep was made by Akerstedt's group, which demonstrated that sleep loss led to altered phytohemagglutinin-stimulated lymphocyte DNA synthesis in vitro (Palmblad et al., 1979) . Shortly thereafter, other investigators took the approach of characterizing the sleep-promoting actions (or wake-promoting actions) of known mediators of inflammation such as adenosine (Radulovacki et al., 1982) and prostaglandins (Haubrich et al., 1973; Laychock et al., 1980; Ueno et al., 1982) , albeit this work was not framed within the context of a link between sleep and the immune system. These early studies set the stage by first demonstrating that sleep loss affected immunocyte function, and then that bacterial-derived substances alter sleep. As such, bi-directional interactions between sleep and the immune response were established. By 1983 (Krueger et al., 1983 interleukin-1 was linked to sleep regulation. This discovery led to the expansion of research relating sleep to host defense and the cytokine mechanisms involved. The topic of cytokines and sleep was the focus of an earlier special issue of Brain, Behavior, and Immunity (Opp, 2004) .
The knowledge that bacterial-derived products altered sleep drove research focused on infection-induced alterations in sleep. In a series of studies, Toth and colleagues demonstrated the extent to which infection altered sleep of laboratory animals. Pathogens included Gram-positive and Gram-negative bacteria, viruses, fungi, and parasites [reviewed (Opp et al., 2007; Toth, 1999; Toth and Opp, 2002) ]. Seminal studies by Norman also demonstrated the extent to which sleep of individuals infected with HIV was altered (Norman et al., 1992 (Norman et al., , 1990 (Norman et al., , 1988 . Studies of HIV-induced alterations in sleep have since been conducted by many groups [reviewed (Toth and Opp, 2002) ] and continues to be a topic of active research, as evidenced by the contribution of Lee et al., in this issue (Gay et al., 2015) . Although it is clear that sleep is altered, the question of whether altered sleep during infection facilitates recovery remains. Some intriguing ecological studies of the energetic cost of fueling the immune system suggest a phylogenetic relationship between sleep duration and parasite load (Opp, 2009; Preston et al., 2009) . A retrospective study by Toth suggests sleep patterns may be important to survival from infections, as rabbits with robust early sleep responses to infectious challenge have a better prognosis than rabbits with ''poor sleep'' responses during the course of infection (Toth et al., 1993) . Collectively, data suggest sleep, as part of the acute phase response to infection may be beneficial for recovery, but definitive studies to test this hypothesis remain to be conducted. 
